ORTEXORTEX News
Tracking OSPN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
OS
Earnings PreviewOSPN

OneSpan Heads Into Q3 Print Trading Above Analyst Targets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 28 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

OSPN reports Q3 results on October 29 having moved meaningfully above the Street's price targets, a gap that concentrates attention on whether the underlying business can justify a valuation the consensus has yet to catch up with.

The stock closed at $20.36, up 14% over the past month and 11.6% on the week, yet the analyst mean target sits at $18.00, a level the shares have already cleared. The most recent target moves, both from August after the last print, took DA Davidson to $16 and Rosenblatt to $18, both still below the current price. Coverage is thin, with only two active voices on the name, and neither has updated since August 5. Options positioning gives little away: the put/call ratio of 0.011 is essentially flat with its 20-day average of 0.011, a z-score close to zero, signalling no unusual hedging demand heading into the event. Short sellers have been backing away. SI dropped 5.1% in a single session on October 26, and is down 14% over the past month, now representing 8.8% of the float. Borrow availability is loose at 771%, meaning roughly seven shares are available to lend for every one currently borrowed, so there is no squeeze pressure building in the lending market even as the stock rallies.

The bull case rests on OneSpan's deepening penetration of the top-tier banking market and a go-to-market buildout under CRO Shaun Bierweiler, with new Alliances and Marketing hires aimed at widening the partner-led distribution channel in cybersecurity and digital agreements. Bears point to concentrated customer risk, heavy reliance on a small number of financial institutions, and a cash position that has more than halved to $49.8 million from $92.9 million a year ago after buybacks, dividends, and the Build38 acquisition. The stock trades at roughly 1.5x forward EV/Sales, and EV/EBITDA has drifted lower over the past month to 9.6x, an expanding multiple compression argument that gives the bear case some structural support even before the revenue concentration risk is priced in.

On ownership, Dimensional Fund Advisors filed a fresh Schedule 13G on October 8 establishing a 5.2% passive stake, the most recent institutional move of note. BlackRock updated its own 13G in August at 10.1%. No Schedule 13D activist filing is on record, and the disclosure caveat applies: positions are as last disclosed around the 5% threshold, and holders can exit without a subsequent filing. The CFO's only recent open-market activity was a $289,000 sale in June at $14.45, a price the stock has since cleared by 40%. All September insider transactions were equity-award mechanics, grants and tax withholdings, not discretionary trades.

After the last print in August the stock gained roughly 2.7% on the day; before that, in June, it fell 3.7%. The pattern is modest reactions either way, which matters given the stock is already running hot. Tomorrow's print tests whether revenue quality and cash generation can convince a thin analyst community to revise targets higher, or whether the rally has simply run ahead of what the numbers can deliver.

Stocks in this article

See the live data behind this article on ORTEX.

Open OSPN on ORTEX →

How this article was generated

Generated
28 Oct 2026, 04:27
Data as of
28 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.